tiprankstipranks
Advertisement

VAMO - ETF AI Analysis

Compare

Top Page

VAMO

Cambria Value & Momentum ETF (VAMO)

Rating:64Neutral
Price Target:
VAMO, the Cambria Value & Momentum ETF, has a solid overall rating, mainly because several of its top holdings combine strong financial performance with supportive technical trends and reasonable valuations. Standout contributors include Catalyst Pharma, Alcoa, and IES Holdings, which show robust earnings, positive outlooks, and healthy balance sheets, while names like BorgWarner and Nutex Health introduce some risk through signs of overvaluation, overbought technicals, and legal or profitability challenges. The main risk factor is that many holdings share similar momentum-driven and valuation-sensitive profiles, which can make the fund more vulnerable if market sentiment turns against these types of stocks.
Positive Factors
Positive Year-To-Date Performance
The fund has delivered a modestly positive return so far this year, showing that its value-and-momentum approach has recently added some growth.
Strong Contribution From Select Top Holdings
Several key positions, such as TD SYNNEX and Bread Financial, have shown strong gains, helping support the ETF’s overall results.
Broad Sector Diversification
The ETF spreads its investments across many sectors, including financials, consumer cyclical, energy, industrials, and health care, which can help reduce the impact of weakness in any single industry.
Negative Factors
Relatively High Expense Ratio
The fund’s management fee is on the higher side for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Recent Short-Term Weakness
The ETF has slipped over the last three months, indicating some recent performance softness despite its positive year-to-date result.
Concentrated U.S. Market Exposure
With the vast majority of its holdings in U.S. companies, the fund offers limited geographic diversification and is heavily tied to the U.S. market’s ups and downs.

VAMO vs. SPDR S&P 500 ETF (SPY)

VAMO Summary

The Cambria Value & Momentum ETF (VAMO) is an actively managed fund that looks for U.S. stocks that are both cheap (value) and showing strong recent performance (momentum), rather than tracking a set index. It invests across many sectors, including financials, consumer companies, and energy. Well-known names in the fund include TD SYNNEX and Kohl’s. Someone might consider VAMO if they want a single fund that aims for growth while spreading money across many different industries. A key risk is that these stocks can be volatile and the ETF can go up and down significantly with the stock market.
How much will it cost me?The Cambria Value & Momentum ETF (VAMO) has an expense ratio of 0.65%, which means you’ll pay $6.50 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, using a quantitative strategy to select stocks based on value and momentum factors.
What would affect this ETF?The Cambria Value & Momentum ETF (VAMO), with its focus on U.S. equities and diverse sector exposure, could benefit from economic growth and strong performance in sectors like Financials and Industrials, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns could negatively impact its value-focused strategy, particularly in sectors like Consumer Cyclical and Technology. Regulatory changes or shifts in market sentiment could also influence the performance of its top holdings, such as Serve Robotics and Protagonist Therapeutics.

VAMO Top 10 Holdings

VAMO is leaning into U.S. value names with a clear tilt toward financials and energy, and a healthy dose of economically sensitive stocks. Recent winners like Garrett Motion, EnerSys, and Catalyst Pharma are giving the fund a nice tailwind, as their momentum has stayed strong. Industrial player IES Holdings and auto-tech name Visteon are also quietly pulling their weight. On the flip side, Nutex Health has been lagging, acting as a small brake on performance. Overall, the ETF is diversified across sectors but still driven by a handful of rising U.S. mid-cap stories.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
4.41%$2.15M
Garrett Motion1.52%$739.51K$5.98B212.41%
71
Outperform
TD SYNNEX Corporation1.46%$710.02K$21.61B113.50%
73
Outperform
IES Holdings1.27%$618.16K$14.36B165.61%
76
Outperform
Visteon1.19%$578.92K$3.14B40.64%
73
Outperform
BorgWarner1.17%$568.79K$14.90B132.41%
65
Neutral
Clinigence Holdings1.16%$566.20K$912.40M8.66%
74
Outperform
OPENLANE1.15%$559.30K$3.86B53.15%
70
Outperform
Alcoa1.15%$558.31K$18.97B157.14%
76
Outperform
Catalyst Pharma1.14%$554.27K$3.83B21.05%
83
Outperform

VAMO Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
35.28
Positive
100DMA
35.27
Positive
200DMA
34.31
Positive
Market Momentum
MACD
0.03
Negative
RSI
56.77
Neutral
STOCH
74.86
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VAMO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.10, equal to the 50-day MA of 35.28, and equal to the 200-day MA of 34.31, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 56.77 is Neutral, neither overbought nor oversold. The STOCH value of 74.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VAMO.

VAMO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$48.42M0.65%
64
Neutral
$95.93M0.89%
72
Outperform
$95.07M0.65%
72
Outperform
$93.60M0.85%
74
Outperform
$90.47M0.75%
69
Neutral
$87.23M0.52%
72
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VAMO
Cambria Value & Momentum ETF
35.50
5.77
19.41%
BAMD
Brookstone Dividend Stock ETF
YALL
God Bless America ETF
STNC
Stance Equity ESG Large Cap Core ETF
SOVF
Sovereign's Capital Flourish Fund
RFDA
RiverFront Dynamic US Dividend Advantage ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement